Phase I study of 5-azacytidine and oxaliplatin in patients with advanced cancers relapsed or refractory to platinum compounds

被引：0

作者：

Tsimberidou, Apostolia M. ^{[1
]}

Culotta, Kirk ^{[1
]}

Wistuba, Ignacio ^{[1
]}

Fu, Siqing ^{[1
]}

Naing, Aung ^{[1
]}

Falchook, Gerald ^{[1
]}

Piha-Paul, Sarina ^{[1
]}

Zinner, Ralph ^{[1
]}

Rodriguez-Canales, Jaime ^{[1
]}

He, Guangan ^{[1
]}

Siddik, Zahid H. ^{[1
]}

Jelinek, Jaroslav ^{[2
]}

Chung, Woonbok ^{[2
]}

Ye, Yang ^{[1
]}

Said, Rabih ^{[3
]}

Hess, Kenneth ^{[1
]}

Stewart, David J. ^{[4
]}

Kurzrock, Razelle ^{[5
]}

Issa, Jean-Pierre ^{[2
]}

机构：

[1] UT MD Anderson Canc Ctr, Houston, TX USA

[2] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19122 USA

[3] UT Hlth Sci Ctr, Houston, TX USA

[4] Ottawa Hosp, Ctr Canc, Ottawa, ON, Canada

[5] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA USA

来源：

CANCER RESEARCH | 2014年 / 74卷 / 19期

关键词：

D O I：

10.1158/1538-7445.AM2014-CT201

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CT201

引用

页数：2

共 50 条

[21] PHASE-1 STUDY OF PYRAZOFURIN AND 5-AZACYTIDINE IN REFRACTORY ADULT ACUTE-LEUKEMIA
MARTELO, OJ
BROUN, GO
PETRUSKA, PJ
CANCER TREATMENT REPORTS, 1981, 65 (3-4): : 237 - 239
[22] Phase I Study of Inhaled 5-Azacytidine (5-Aza) in Patients (Pts) with Advanced Non-Small Cell Lung Cancer (NSCLC)
Cheng, H.
Fan, N.
Zou, Y.
Shah, C.
Halmos, B.
Bhagat, T.
Gucalp, R.
Piperdi, B.
Kim, M.
Verma, A.
Spivack, S.
Perez-Soler, R.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S356 - S356
[23] PHASE-I STUDY USING COMBINATION OF HYDROXYUREA AND 5-AZACYTIDINE (NSC 102816)
LOMEN, PL
KHILANANI, P
KESSEL, D
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 313 - 313
[24] PHASE IB/II STUDY OF NIVOLUMAB IN COMBINATION WITH 5-AZACYTIDINE (AZA) IN PATIENTS (PTS) WITH RELAPSED ACUTE MYELOID LEUKEMIA (AML)
Daver, N.
Cortes, J.
Ravandi, F.
Basu, S.
Garcia-Manero, G.
Jabbour, E.
Pemmaraju, N.
Hendrickson, S.
Pierce, S.
Ning, J.
Gonzales, G.
Konopleva, M.
Andreeff, M.
Borthakur, G.
Bueso-Ramos, C.
Blando, J.
Allison, J.
Kantarjian, H.
Sharma, P.
HAEMATOLOGICA, 2016, 101 : 42 - 43
[25] A Phase I study of pevonedistat plus capecitabine plus oxaliplatin in patients with advanced gastric cancer refractory to platinum (NCCH-1811)
Shoji, Hirokazu
Takahari, Daisuke
Hara, Hiroki
Nagashima, Kengo
Adachi, Jun
Boku, Narikazu
FUTURE SCIENCE OA, 2021, 7 (07):
[26] PHASE 2 STUDY OF 5-AZACYTIDINE (NSC-102816) IN TREATMENT OF ADVANCED GASTROINTESTINAL CANCER
MOERTEL, CG
SCHUTT, AJ
REITEMEIER, RJ
HAHN, RG
CANCER CHEMOTHERAPY REPORTS PART 1, 1972, 56 (05): : 649 - 652
[27] PHASE-I STUDY OF 5-AZACYTIDINE USING 24 HOURS CONTINUOUS INFUSION FOR 5 DAYS
LOMEN, PL
VAITKEVICIUS, VK
SAMSON, MK
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 52 - 52
[28] PHASE-2 STUDY OF 5-AZACYTIDINE IN SOLID TUMORS
WEISS, AJ
METTER, GE
NEALON, TF
KEANAN, JP
RAMIREZ, G
SWAIMINATHAN, A
FLETCHER, WS
MOSS, SE
MANTHEI, RW
CANCER TREATMENT REPORTS, 1977, 61 (01): : 55 - 58
[29] PHASE-II STUDY OF 5-AZACYTIDINE IN SARCOMAS OF BONE
SRINIVASAN, U
REAMAN, GH
POPLACK, DG
GLAUBIGER, DL
LEVINE, AS
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (04): : 411 - 415
[30] PHASE-I STUDY USING COMBINATION OF HYDROXYUREA AND 5-AZACYTIDINE (NSC-102816)
LOMEN, PL
KHILANANI, P
KESSEL, D
NEOPLASMA, 1980, 27 (01) : 101 - 106

← 1 2 3 4 5 →